CROHN'S DISEASE PATIENTS WITH USTEKINUMAB-INDUCED REMISSION ARE CHARACTERIZED BY HIGH BASELINE IL23 RECEPTOR EXPRESSION IN THE LAMINA PROPRIA TH1 CELLS

被引：0
|
作者：
Onali, S. [1 ]
Di, Petrillo A. [1 ]
Favale, A. [1 ]
Carpineti, C. [1 ]
Cadoni, M. [1 ]
Loddo, E. [1 ]
Fantini, M. C. [1 ]
机构：
[1] Univ Cagliari, Med Sci & Publ Healt, Cagliari, Italy
来源：
DIGESTIVE AND LIVER DISEASE | 2023年 / 55卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
T.06.1
引用
收藏
页码：S159 / S159
页数：1
相关论文
共 50 条
  • [1] CROHN'S DISEASE PATIENTS WITH USTEKINUMAB-INDUCED REMISSION ARE CHARACTERIZED BY HIGH BASELINE P35 CYTOKINES SUBUNITS IN LPMC AND HIGH IL-23 RECEPTOR EXPRESSION IN THE LAMINA PROPRIA TH1 CELLS
    Onali, S.
    Di Petrillo, A.
    Raho, N.
    Favale, A.
    Cadoni, M.
    Loddo, E.
    Carpineti, C.
    Fantini, M. C.
    DIGESTIVE AND LIVER DISEASE, 2024, 56 : S161 - S161
  • [2] Crohn's disease patients with Ustekinumab-induced remission are characterized by high baseline p35 cytokines subunits in LPMC and high IL-23 receptor expression in the lamina propria Th1 cells
    Onali, S.
    Di Petrillo, A.
    Raho, N.
    Favale, A.
    Carpineti, C.
    Cadoni, M.
    Loddo, E.
    Fantini, M. C.
    JOURNAL OF CROHNS & COLITIS, 2024, 18 : I937 - I939
  • [3] IL23 differentially regulates the Th1/Th17 balance in ulcerative colitis and Crohn's disease
    Kobayashi, T.
    Okamoto, S.
    Hisamatsu, T.
    Kamada, N.
    Chinen, H.
    Saito, R.
    Kitazume, M. T.
    Nakazawa, A.
    Sugita, A.
    Koganei, K.
    Isobe, K.
    Hibi, T.
    GUT, 2008, 57 (12) : 1682 - 1689
  • [4] TL1A Produced by Lamina Propria Macrophages Induces Th1 and Th17 Immune Responses in Cooperation with IL-23 in Patients with Crohn's Disease
    Kamada, Nobuhiko
    Hisamatsu, Tadakazu
    Honda, Haruki
    Kobayashi, Taku
    Chinen, Hiroshi
    Takayama, Tetsuro
    Kitazume, Mina T.
    Okamoto, Susumu
    Koganei, Kazutaka
    Sugita, Akira
    Kanai, Takanori
    Hibi, Toshifumi
    INFLAMMATORY BOWEL DISEASES, 2010, 16 (04) : 568 - 575
  • [5] Effector Th-1 Cells with Cytotoxic Function in the Intestinal Lamina Propria of Patients with Crohn's Disease
    P. Mariani
    A. Bachetoni
    M. D'Alessandro
    D. Lomanto
    P. Mazzocchi
    V. Speranza
    Digestive Diseases and Sciences, 2000, 45 : 2029 - 2035
  • [6] Effector Th-1 cells with cytotoxic function in the intestinal lamina propria of patients with Crohn's disease
    Mariani, P
    Bachetoni, A
    D'Alessandro, M
    Lomanto, D
    Mazzocchi, P
    Speranza, V
    DIGESTIVE DISEASES AND SCIENCES, 2000, 45 (10) : 2029 - 2035
  • [7] Increased expression of interleukin-12 receptor β2 on lamina propria mononuclear cells of patients with active Crohn's disease
    A. Stallmach
    T. Marth
    N. Adrian
    B. Wittig
    K.-W. Ecker
    M. Schilling
    M. Zeitz
    International Journal of Colorectal Disease, 2002, 17 : 303 - 310
  • [8] RISANKIZUMAB, BUT NOT USTEKINUMAB OR VEDOLIZUMAB, DOWNREGULATES IL-23-INDUCED MUCOSAL PATHOGENIC TH17 CELLS IN PATIENTS WITH CROHN'S DISEASE
    Noviello, Daniele
    Dusetti, Irene
    Pivorunas, Valerie L.
    Conforti, Francesco Simone
    Amoroso, Chiara
    Ciafardini, Clorinda
    Lovati, Ambra E.
    Vecchi, Maurizio
    Facciotti, Federica
    Paroni, Moira
    Caprioli, Flavio
    GASTROENTEROLOGY, 2024, 166 (05) : S792 - S792
  • [9] Ustekinumab decreases circulating Th1, Th17, and MAIT cells in Crohn's disease
    Lord, J.
    Konecny, A.
    Shows, D.
    JOURNAL OF CROHNS & COLITIS, 2023, 17 : I221 - I221
  • [10] Risankizumab, but not ustekinumab or vedolizumab, downregulates IL-23-induced mucosal pathogenic Th17 cells in patients with Crohn's disease
    Noviello, D.
    Dusetti, I.
    Pivorunas, V.
    Lovati, A. E.
    Ciafardini, C.
    Amoroso, C.
    Conforti, F.
    Sed, N. Piazza O.
    Vecchi, M.
    Facciotti, F.
    Paroni, M.
    Caprioli, F.
    JOURNAL OF CROHNS & COLITIS, 2024, 18 : I1769 - I1770
12345